Search results
Results from the WOW.Com Content Network
Cognitive changes such as problems with memory or processing speed. ... Getting enough sleep, ideally 7 to 9 hours per day ... Statins or other medications to treat high cholesterol levels.
The most important adverse side effects are muscle problems, an increased risk of diabetes mellitus, and increased liver enzymes in the blood due to liver damage. [5] [66] Over 5 years of treatment statins result in 75 cases of diabetes, 7.5 cases of bleeding stroke, and 5 cases of muscle damage per 10,000 people treated. [35]
With the exception of occasional breakthroughs for diseases like hepatitis C, it is becoming harder and harder to find drugs that offer clear-cut clinical advantages over existing treatments. Between 2003 and 2011, the success rate for clinical trials fell, the time from trial to approval rose, and the ratio of approved drugs to trial drugs ...
SAAM may affect people after long-term statin use even if they had no previous muscular side effects. [4] A differentiating feature between this and more benign statin side effects is SAAM typically has a late onset. While muscle pain (myalgia) is seen in 9-20% of patients treated with statins, it typically occurs in the first month of treatment.
For the prevention of cardiovascular disease, statins are a first-line treatment. [6] It is taken by mouth. [6] Common side effects include joint pain, diarrhea, heartburn, nausea, and muscle pains. [6] Serious side effects may include rhabdomyolysis, liver problems, and diabetes. [6] Use during pregnancy may harm the fetus. [6]
Healthy sleep improves cognitive skills, such as attention, memory, reasoning, and problem-solving. Good sleep hygiene can also improve mental health and psychological well-being.
Sleep apnea. Problems with your adrenal glands ... These include sleep apnea, diabetes, high cholesterol, thyroid problems, and chronic kidney disease. ... The treatment for hypertension will ...
This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.